WO2010110545A2 - 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물 - Google Patents
신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물 Download PDFInfo
- Publication number
- WO2010110545A2 WO2010110545A2 PCT/KR2010/001656 KR2010001656W WO2010110545A2 WO 2010110545 A2 WO2010110545 A2 WO 2010110545A2 KR 2010001656 W KR2010001656 W KR 2010001656W WO 2010110545 A2 WO2010110545 A2 WO 2010110545A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- same
- pharmaceutical composition
- hydroxamate derivative
- production method
- derivative
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1007092A BRPI1007092B8 (pt) | 2009-03-27 | 2010-03-18 | Derivados de hidroxamato, uso dos derivados de hidroxamato, composições farmacêuticas e método de produção de derivados de hidroxamato |
EP10756300.9A EP2412706B1 (en) | 2009-03-27 | 2010-03-18 | Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
CN201080013979.6A CN102365270B (zh) | 2009-03-27 | 2010-03-18 | 新的氧肟酸衍生物、其制备方法以及包含它的药物组合物 |
AU2010229591A AU2010229591B2 (en) | 2009-03-27 | 2010-03-18 | Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
ES10756300.9T ES2525566T3 (es) | 2009-03-27 | 2010-03-18 | Nuevo derivado de hidroxamato, método para producirlo y composición farmacéutica que lo contiene |
MX2011010065A MX2011010065A (es) | 2009-03-27 | 2010-03-18 | Novedoso derivado de hidroxamato, un metodo de produccion del mismo y una composicion farmaceutica que comprende el mismo. |
US13/258,630 US8466161B2 (en) | 2009-03-27 | 2010-03-18 | Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
CA2754085A CA2754085C (en) | 2009-03-27 | 2010-03-18 | Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
JP2012501923A JP5555868B2 (ja) | 2009-03-27 | 2010-03-18 | 新規なヒドロキサメート誘導体、その作製方法、及びこれを含有する薬学的組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20090026578 | 2009-03-27 | ||
KR10-2009-0026578 | 2009-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010110545A2 true WO2010110545A2 (ko) | 2010-09-30 |
WO2010110545A3 WO2010110545A3 (ko) | 2011-03-24 |
Family
ID=42781631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/001656 WO2010110545A2 (ko) | 2009-03-27 | 2010-03-18 | 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8466161B2 (ko) |
EP (1) | EP2412706B1 (ko) |
JP (1) | JP5555868B2 (ko) |
KR (1) | KR101168801B1 (ko) |
CN (1) | CN102365270B (ko) |
AU (1) | AU2010229591B2 (ko) |
BR (1) | BRPI1007092B8 (ko) |
CA (1) | CA2754085C (ko) |
ES (1) | ES2525566T3 (ko) |
MX (1) | MX2011010065A (ko) |
WO (1) | WO2010110545A2 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2771321A1 (en) * | 2011-10-28 | 2014-09-03 | Chong Kun Dang Pharmaceutical Corp. | Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
WO2018066946A1 (en) | 2016-10-04 | 2018-04-12 | Chong Kun Dang Pharmaceutical Corp. | Pharmaceutical combinations of histone deacetylase inhibitor and proteasome inhibitor or immunomodulatory drug for the treatment of hematological cancer |
WO2018102261A3 (en) * | 2016-11-29 | 2018-11-01 | Xavier University Of Louisiana | Boronic derivatives hydroxamates as anticancer agents |
US11420950B2 (en) | 2015-05-22 | 2022-08-23 | Chong Kun Dang Pharmaceutical Corp. | Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2684396T3 (es) * | 2012-08-31 | 2018-10-02 | Novadrug, Llc | Heterociclil carboxamidas para tratar enfermedades víricas |
US9878986B2 (en) * | 2013-04-29 | 2018-01-30 | Chong Kun Dang Pharmaceutical Corp. | Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same |
TR201900057T4 (tr) | 2013-12-12 | 2019-01-21 | Chong Kun Dang Pharmaceutical Corp | Selektif histon deasetilaz (HDAC) inhibitörleri olarak yeni azaindol deriveleri ve bunları içeren farmasötik bileşimler. |
RU2016148863A (ru) * | 2014-05-14 | 2018-06-18 | Дзе Риджентс Оф Дзе Юниверсити Оф Колорадо, Э Боди Корпорейт | Гетероциклические гидроксамовые кислоты в качестве ингибиторов протеин-деацетилазы и двойных ингибиторов протеин-деацетилазы-протеин-киназы и способы их применения |
WO2019018562A1 (en) | 2017-07-19 | 2019-01-24 | Ideaya Biosciences, Inc. | AMIDO COMPOUND AS MODULATORS OF AHR |
US10793551B2 (en) | 2017-10-19 | 2020-10-06 | Effector Therapeutics Inc. | Benzimidazole-indole inhibitors of Mnk1 and Mnk2 |
KR102236356B1 (ko) * | 2017-11-24 | 2021-04-05 | 주식회사 종근당 | 루푸스의 예방 또는 치료를 위한 조성물 |
CN109096272B (zh) * | 2018-09-27 | 2021-04-02 | 沈阳药科大学 | 一种具有抗肿瘤活性的吲哚异羟肟酸类化合物及其应用 |
US11596612B1 (en) | 2022-03-08 | 2023-03-07 | PTC Innovations, LLC | Topical anesthetics |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US771760A (en) | 1902-07-12 | 1904-10-04 | David M Balch | Process of treating seaweed. |
EP0847992A1 (en) | 1996-09-30 | 1998-06-17 | Mitsui Chemicals, Inc. | Benzamide derivatives, useful as cell differentiation inducers |
WO2002022577A2 (en) | 2000-09-01 | 2002-03-21 | Novartis Ag | Hydroxamate derivatives useful as deacetylase inhibitors |
WO2002030879A2 (en) | 2000-09-29 | 2002-04-18 | Prolifix Limited | Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
WO2004069823A1 (en) | 2003-02-04 | 2004-08-19 | Methylgene, Inc. | Inhibitors of histone deacetylase |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700811A (en) | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
IT1283637B1 (it) | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
US20070060614A1 (en) | 2002-03-04 | 2007-03-15 | Bacopoulos Nicholas G | Methods of treating cancer with hdac inhibitors |
US7135493B2 (en) * | 2003-01-13 | 2006-11-14 | Astellas Pharma Inc. | HDAC inhibitor |
WO2004110989A1 (en) * | 2003-05-14 | 2004-12-23 | Bayer Pharmaceuticals Corporation | N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
EP1937650B1 (en) * | 2005-09-08 | 2011-06-15 | S*BIO Pte Ltd | Heterocyclic compounds |
KR20090077914A (ko) * | 2006-09-11 | 2009-07-16 | 쿠리스 인코퍼레이션 | 항증식제로서의 다작용성 소분자 |
KR100814098B1 (ko) * | 2006-11-03 | 2008-03-14 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 알킬아미노나프탈렌일옥시 메틸옥트 n-하이드록시엔아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물 |
WO2009002534A1 (en) * | 2007-06-26 | 2008-12-31 | Gilead Colorado, Inc. | Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
-
2010
- 2010-03-17 KR KR1020100023575A patent/KR101168801B1/ko active IP Right Grant
- 2010-03-18 AU AU2010229591A patent/AU2010229591B2/en active Active
- 2010-03-18 ES ES10756300.9T patent/ES2525566T3/es active Active
- 2010-03-18 WO PCT/KR2010/001656 patent/WO2010110545A2/ko active Application Filing
- 2010-03-18 EP EP10756300.9A patent/EP2412706B1/en active Active
- 2010-03-18 US US13/258,630 patent/US8466161B2/en active Active
- 2010-03-18 CN CN201080013979.6A patent/CN102365270B/zh active Active
- 2010-03-18 CA CA2754085A patent/CA2754085C/en active Active
- 2010-03-18 JP JP2012501923A patent/JP5555868B2/ja not_active Expired - Fee Related
- 2010-03-18 MX MX2011010065A patent/MX2011010065A/es active IP Right Grant
- 2010-03-18 BR BRPI1007092A patent/BRPI1007092B8/pt active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US771760A (en) | 1902-07-12 | 1904-10-04 | David M Balch | Process of treating seaweed. |
EP0847992A1 (en) | 1996-09-30 | 1998-06-17 | Mitsui Chemicals, Inc. | Benzamide derivatives, useful as cell differentiation inducers |
WO2002022577A2 (en) | 2000-09-01 | 2002-03-21 | Novartis Ag | Hydroxamate derivatives useful as deacetylase inhibitors |
WO2002030879A2 (en) | 2000-09-29 | 2002-04-18 | Prolifix Limited | Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
WO2004069823A1 (en) | 2003-02-04 | 2004-08-19 | Methylgene, Inc. | Inhibitors of histone deacetylase |
Non-Patent Citations (11)
Title |
---|
CANCER RES, vol. 66, 2006, pages 5781 - 5789 |
GABBIANELLI. M. ET AL., BLOOD, vol. 95, 2000, pages 3555 - 3561 |
INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 33, 2008, pages 637 - 646 |
JOHNSTONE. R.W, NAT. REV. DRUG DISCOV., vol. 1, 2002, pages 287 - 299 |
LI. S. ET AL., J. BIOL. CHEM., vol. 274, 1999, pages 7803 - 7815 |
MARKS ET AL., NATURE REVIEWS, vol. 1, 2001, pages 194 - 202 |
MARKS, P.A ET AL., CURR OPIN. ONCOL., vol. 13, 2001, pages 477 - 483 |
MOL CANCER RES, vol. 5, 2007, pages 981 |
MORRIS, G. A. ET AL., TETRAHEDRON LETT., vol. 42, 2001, pages 2093 |
See also references of EP2412706A4 |
STEFFAN, J. S. ET AL., NATURE, vol. 413, 2001, pages 739 - 743 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2771321A1 (en) * | 2011-10-28 | 2014-09-03 | Chong Kun Dang Pharmaceutical Corp. | Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
EP2771321A4 (en) * | 2011-10-28 | 2015-04-08 | Chong Kun Dang Pharm Corp | HYDROXAMATE DERIVATIVES FOR HDAC INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH |
US11420950B2 (en) | 2015-05-22 | 2022-08-23 | Chong Kun Dang Pharmaceutical Corp. | Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same |
WO2018066946A1 (en) | 2016-10-04 | 2018-04-12 | Chong Kun Dang Pharmaceutical Corp. | Pharmaceutical combinations of histone deacetylase inhibitor and proteasome inhibitor or immunomodulatory drug for the treatment of hematological cancer |
WO2018102261A3 (en) * | 2016-11-29 | 2018-11-01 | Xavier University Of Louisiana | Boronic derivatives hydroxamates as anticancer agents |
US11046715B2 (en) | 2016-11-29 | 2021-06-29 | Xavier University Of Louisiana | Boronic derivatives of hydroxamates as anticancer agents |
Also Published As
Publication number | Publication date |
---|---|
CN102365270B (zh) | 2014-07-30 |
ES2525566T3 (es) | 2014-12-26 |
BRPI1007092B8 (pt) | 2022-07-26 |
EP2412706A2 (en) | 2012-02-01 |
EP2412706B1 (en) | 2014-10-29 |
MX2011010065A (es) | 2011-10-10 |
EP2412706A4 (en) | 2012-05-09 |
US20120028963A1 (en) | 2012-02-02 |
KR101168801B1 (ko) | 2012-07-25 |
JP2012521982A (ja) | 2012-09-20 |
AU2010229591B2 (en) | 2013-01-31 |
KR20100108220A (ko) | 2010-10-06 |
AU2010229591A1 (en) | 2011-10-20 |
US8466161B2 (en) | 2013-06-18 |
CN102365270A (zh) | 2012-02-29 |
JP5555868B2 (ja) | 2014-07-23 |
BRPI1007092B1 (pt) | 2022-07-12 |
BRPI1007092A2 (pt) | 2015-08-18 |
WO2010110545A3 (ko) | 2011-03-24 |
CA2754085A1 (en) | 2010-09-30 |
CA2754085C (en) | 2014-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010110545A2 (ko) | 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물 | |
WO2010135524A8 (en) | Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases | |
MX2012004420A (es) | Compuestos de espiropiperidino y uso farmaceutico de los mismos para tratar diabetes. | |
TN2012000248A1 (en) | Novel spiropiperidine compounds | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
MX2013007336A (es) | Compuestos de bi-heteroarilo como inhibidores de vps34. | |
AU2012214029A8 (en) | Rorgammat inhibitors | |
IN2012DN00639A (ko) | ||
WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
WO2012071509A3 (en) | Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture | |
MX2009012168A (es) | Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta. | |
IN2014KN00948A (ko) | ||
MX2012004780A (es) | Inhibidores de akt. | |
GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
TN2012000458A1 (en) | Uses of dgat1 inhibitors | |
CA2878796C (en) | Derivatives of pyridinone as inhibitors for tissue transglutaminase | |
WO2011028044A3 (ko) | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 | |
WO2011028043A3 (ko) | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 | |
GEP20166481B (en) | (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors | |
WO2009140341A3 (en) | Atorvastatin compositions | |
AU2012277905A8 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080013979.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10756300 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2754085 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010756300 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6989/DELNP/2011 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010229591 Country of ref document: AU Ref document number: 13258630 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012501923 Country of ref document: JP Ref document number: MX/A/2011/010065 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2010229591 Country of ref document: AU Date of ref document: 20100318 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1007092 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1007092 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110927 |